Evaluation of the clinical dose and effectiveness of allopurinol and benzbromarone on hyperuricemia in patients with different renal function
碩士 === 高雄醫學大學 === 臨床藥學研究所 === 96 === Background: There are some noticeable points for urate-lowering therapy. 1. The potential of allopurinol severe cutaneous adverse reactions led to the development of clinical guidelines that advocate dosing of allopurinol according to renal function. For achievin...
Main Authors: | Pei-Fen Chuang, 莊佩芬 |
---|---|
Other Authors: | Yaw-Bin Huang |
Format: | Others |
Language: | zh-TW |
Published: |
2008
|
Online Access: | http://ndltd.ncl.edu.tw/handle/78434176373964277614 |
Similar Items
-
A Head-To-Head Comparison of Benzbromarone and Allopurinol on the Risk of Type 2 Diabetes Mellitus in People With Asymptomatic Hyperuricemia
by: Shih-Wei Lai, et al.
Published: (2021-09-01) -
The Use of Allopurinol and Benzbromarone for Coronary Artery Disease Prophylaxis in Patients with Gout
by: Ching-Huan Wang, et al.
Published: (2014) -
Allopurinol, Benzbromarone, or a Combination in Treating Patients with Gout: Analysis of a Series of Outpatients
by: Valderilio Feijó Azevedo, et al.
Published: (2014-01-01) -
Allopurinol for prevention of progression of kidney disease with hyperuricemia
by: B.H. Santhosh Pai, et al.
Published: (2013-01-01) -
Switching from allopurinol to febuxostat: efficacy and safety in the treatment of hyperuricemia in renal transplant recipients
by: Yanchun Li, et al.
Published: (2019-01-01)